6-[18F]fluoro-A-85380:: An in vivo tracer for the nicotinic acetylcholine receptor

被引:31
|
作者
Scheffel, U
Horti, AG
Koren, AO
Ravert, HT
Banta, JP
Finley, PA
London, ED
Dannals, RF
机构
[1] Johns Hopkins Med Inst, Div Nucl Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Div Radiat Hlth Sci, Baltimore, MD 21205 USA
[3] NIDA, Brain Imaging Ctr, Intramural Res Program, Baltimore, MD USA
[4] CTI Inc, Knoxville, TN USA
关键词
6-[F-18]FA; A-85380; derivative; nicotinic acetylcholine receptor (nAChR); mouse brain distribution; radiotracer; PET;
D O I
10.1016/S0969-8051(99)00082-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
6-[F-18]Fluoro-3-(2(S)-azetidinylmethoxy (6-[F-18]fluoro-A-85380 or 6-[F-18]FA), a new tracer for positron emission tomography, was synthesized by no-carrier-added [F-18] fluorination of 6-iodo-3-((1-tert-butoxycarbonyl-2 (S)-azetidinyl)methoxy)pyridine followed by acidic deprotection. 6-[F-18]FA followed the regional densities of brain nicotinic acetylcholine receptors (nAChRs) reported in the literature. Evidence of binding to nAChRs and high specificity of the binding in vivo was demonstrated by inhibition with nAChR selective ligands as well as with unlabeled 6-FA. A preliminary toxicology study of the 6-FA showed a relatively low biological effect. NUCL MED BIOL 27;1:51-56, 2000. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [41] Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET
    J. R. Ellis
    P. J. Nathan
    V. L. Villemagne
    R. S. Mulligan
    T. Saunder
    K. Young
    C. L. Smith
    J. Welch
    M. Woodward
    K. A. Wesnes
    G. Savage
    C. C. Rowe
    Psychopharmacology, 2009, 202 : 79 - 91
  • [42] Evaluation of dopaminergic presynaptic integrity:: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine
    Doudet, DJ
    Chan, GLY
    Jivan, S
    DeJesus, OT
    McGeer, EG
    English, C
    Ruth, TJ
    Holden, JE
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (03): : 278 - 287
  • [43] In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease
    Schmaljohann, J
    Guendisch, D
    Minnerop, M
    Bucerius, J
    Joe, A
    Reinhardt, M
    Guhlke, S
    Biersack, HJ
    Wuellner, U
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (03) : 305 - 309
  • [44] Characterization of the binding mode of the PET tracer [18F] ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor
    Kuang, Guanglin
    Zhou, Yang
    Zou, Rongfeng
    Halldin, Christer
    Nordberg, Agneta
    Langstrom, Bengt
    Agren, Hans
    Tu, Yaoquan
    RSC ADVANCES, 2017, 7 (32) : 19787 - 19793
  • [46] In vitro/in vivo regional binding at nicotinic receptors of 2-[18F]F-A-85380 in baboon
    Saba, W.
    Valette, H.
    Peyronneau, M. A.
    Hinnen, F.
    Dolle, F.
    Gallezot, J. D.
    Delforge, J.
    Bottlaender, M.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [47] Synthesis and preliminary validation of 6-[18F]-Fluorodopamine ([18F]FDA) as a PET tracer for neuroblastoma
    Vavere, Amy
    Butch, Elizabeth
    Shulkin, Barry
    Snyder, Scott
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [48] 2-[18F]fluoro-A-85380 BPND in brains of smokers and non-smokers:: Validation of extracerebral reference region approach
    Mukhin, Alexey G.
    Chefer, S. I.
    LeFoll, B.
    Matochik, J. A.
    Contoreggi, C. S.
    Kimes, A. S.
    NEUROIMAGE, 2008, 41 : T191 - T191
  • [49] Imaging of the dopamine presynaptic system by PET:: 6-[18F]fluoro-L-DOPA versus 6-[18F]fluoro-L-m-tyrosine
    Doudet, DJ
    Dejesus, OT
    Chan, GLY
    Jivan, S
    Holden, JE
    English, C
    Aigner, TG
    Ruth, TJ
    QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, 1998, : 387 - 391
  • [50] A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease
    Gallagher, Catherine L.
    Christian, Bradley T.
    Holden, James E.
    Dejesus, Onofre T.
    Nickles, Robert J.
    Buyan-Dent, Laura
    Bendlin, Barbara B.
    Harding, Sandra J.
    Stone, Charles K.
    Mueller, Barb
    Johnson, Sterling C.
    MOVEMENT DISORDERS, 2011, 26 (11) : 2032 - 2038